Trial CTRI/2020/08/027170
Publication Kulkarni P, SSRN, 2021
Primary outcome on the report: Ratio of geometric mean titre (GMT) of IgG antibodies against SARS-CoV-2 S protein (anti-S IgG) at 1 month after the second dose of vaccine

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.